Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 4/20 | 0.46 |
| ▸ | CHRM2 known ✓ | P08172 | 3/20 | 0.46 |
| ▸ | CHRM3 known ✓ | P20309 | 3/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL28986896 | 0.98 | CHRM1 (0.44) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| SCHEMBL340908 | 0.93 | CHRM1 (0.52) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Water SCHEMBL21326730 | 0.91 | CHRM1 (0.50) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Ammonia Solution, Strong SCHEMBL29221185 | 0.91 | CHRM1 (0.50) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Hydrochloric Acid SCHEMBL28734137 | 0.89 | CHRM1 (0.48) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Sulfuric Acid SCHEMBL28116564 | 0.85 | CHRM1 (0.42) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Sulfuric Acid SCHEMBL16660529 | 0.85 | CHRM1 (0.42) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Sulfuric Acid SCHEMBL28478530 | 0.84 | CHRM2 (0.36) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Sulfuric Acid SCHEMBL4974915 | 0.82 | HCAR2 (0.35) | SMN1; SMN2ALDH1A1GAATHRB | |
| SCHEMBL28150485 | 0.81 | CHRM1 (0.52) | CHRM1CHRM2CHRM4CHRM5CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 687 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739418-A2 | ONE-PASS DEOXYGENATION METHOD FOR POLYACRYLAMIDE PRODUCTION | KEMIRA OYJ (FI) | 2026-05-13 | — | — | EP | claimed |
| EP-4728136-A1 | STRENGTH SYNERGY BETWEEN POLYMER AND PAPERMAKING STRENGTH AID | Ecolab USA, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4716777-A2 | USE OF AMPHOTERIC EMULSION POLYMERS WITH STRENGTH RESINS AS RETENTION AND DRAINAGE AIDS | KEMIRA OYJ (FI) | 2026-04-01 | — | — | EP | claimed |
| US-12553188-B2 | GPAM compositions and methods | KEMIRA OYJ (FI) | 2026-02-17 | — | — | US | claimed |
| EP-4683950-A1 | DUAL EMULSIFICATION OF ALKENYL SUCCINIC ANHYDRIDE TO IMPROVE SIZING PERFORMANCE AND STABILITY | KEMIRA OYJ (FI) | 2026-01-28 | — | — | EP | claimed |
| US-20250215649-A1 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYSACCHARIDE PROMOTER | KEMIRA OYJ (FI) | 2025-07-03 | — | — | US | claimed |
| US-20250137200-A1 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYMERIC PROMOTER | KEMIRA OYJ (FI) | 2025-05-01 | — | — | US | claimed |
| EP-4256009-B1 | OIL-IN-WATER EMULSIONS | QUADRISE INT LTD (GB) | 2025-04-09 | — | — | EP | claimed |
| WO-2025072390-A1 | USE OF QUICK INVERSION CATIONIC EMULSION POLYMERS WITH POLYVINYLAMINES AS RETENTION AND DRAINAGE AIDS | KEMIRA OYJ (FI) | 2025-04-03 | — | — | WO | claimed |
| WO-2025015262-A2 | ONE-PASS DEOXYGENATION METHOD FOR POLYACRYLAMIDE PRODUCTION | KEMIRA OYJ (FI) | 2025-01-16 | — | — | WO | claimed |
| EP-1282732-A4 | FLUORESCENT MONOMERS AND TAGGED TREATMENT POLYMERS CONTAINING SAME FOR USE IN INDUSTRIAL WATER SYSTEMS | ONDEO NALCO CO (US) | 2004-12-22 | — | — | EP | claimed |
| US-20040135125-A1 | Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems | ECOLAB USA INC. | 2004-07-15 | — | — | US | claimed |
| US-20040135124-A1 | Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems | ECOLAB USA INC. | 2004-07-15 | — | — | US | claimed |
| US-6753388-B1 | WATER-SOLUBLE, CROSSLINKED POLYMERS COMPRISING (CO)MONOMERS OF (METH)ACRYLAMIDE, (METH)ACRYLIC ACID, SODIUM (METH)ACRYLATE, AMMONIUM (METH)ACRYLATE, 2-ACRYLAMIDO-2-METHYLPROPANESULFONIC ACID, AND/OR DIALKYLAMINOALKYL (METH)ACRYLATE OR SALTS | NALCO COMPANY | 2004-06-22 | — | — | US | claimed |
| WO-2004050791-A1 | DRILLING FLUID AND METHODS OF USE THEREOF | GENESIS INTERNATIONAL OILFIELD SERVICES INC. (CA) | 2004-06-17 | — | — | WO | claimed |
| WO-2004043412-A1 | WATER SOLUBLE MONOMERS AND POLYMERS FOR PROTECTING SUBTRATES FROM ULTRAVIOLET LIGHT | NALCO COMPANY (US) | 2004-05-27 | — | — | WO | claimed |
| US-6645428-B1 | Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems | ONDEO NALCO COMPANY | 2003-11-11 | — | — | US | claimed |
| EP-1282732-A1 | FLUORESCENT MONOMERS AND TAGGED TREATMENT POLYMERS CONTAINING SAME FOR USE IN INDUSTRIAL WATER SYSTEMS | Ondeo Nalco Company (US) | 2003-02-12 | — | — | EP | claimed |
| US-6344531-B1 | Fluorescent water-soluble polymers | NALCO CHEMICAL COMPANY | 2002-02-05 | — | — | US | claimed |
| WO-2001081654-A1 | FLUORESCENT MONOMERS AND TAGGED TREATMENT POLYMERS CONTAINING SAME FOR USE IN INDUSTRIAL WATER SYSTEMS | ONDEO NALCO COMPANY (US) | 2001-11-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12553188-B2 | GPAM compositions and methods | PGM2, SLC6A9, GNMT | CHRM1 848/4885CHRM2 680/4885CHRM3 1722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.